Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.895
-0.003 (-0.36%)
Nov 21, 2024, 1:04 PM EST - Market open
Tempest Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 22.12 | 39.23 | 31.23 | 51.83 | 18.82 | 3.24 |
Cash & Short-Term Investments | 22.12 | 39.23 | 31.23 | 51.83 | 18.82 | 3.24 |
Cash Growth | 98.92% | 25.62% | -39.74% | 175.39% | 480.15% | - |
Other Receivables | - | - | - | - | - | 0 |
Receivables | - | - | - | - | 0.26 | 0.2 |
Prepaid Expenses | 1.44 | 0.7 | 0.7 | 0.95 | 0.25 | 0.06 |
Other Current Assets | - | 0.43 | 1.02 | 16.19 | 0.5 | 0.26 |
Total Current Assets | 23.55 | 40.36 | 32.95 | 68.96 | 19.83 | 3.76 |
Property, Plant & Equipment | 9.84 | 10.79 | 12.71 | 4.16 | 2.99 | 3.75 |
Other Long-Term Assets | 0.45 | 0.45 | 0.43 | 0.11 | 0.05 | 0.05 |
Total Assets | 33.84 | 51.6 | 46.09 | 73.24 | 22.86 | 7.57 |
Accounts Payable | 1.7 | 0.85 | 1.11 | 0.99 | 1.07 | 1.65 |
Accrued Expenses | 2.94 | 3.33 | 4.31 | 2.59 | 1.44 | 1.95 |
Current Portion of Long-Term Debt | 8.5 | 4.29 | - | - | - | - |
Current Portion of Leases | 0.83 | 0.95 | 1.41 | 1.44 | 0.71 | 0.03 |
Other Current Liabilities | - | - | 0.45 | 15 | - | - |
Total Current Liabilities | 13.97 | 9.41 | 7.28 | 20.03 | 3.22 | 3.63 |
Long-Term Debt | - | 6.26 | 10.37 | 15.07 | - | - |
Long-Term Leases | 8.41 | 9.16 | 10.33 | 2.03 | 1.73 | 2.33 |
Total Liabilities | 22.38 | 24.84 | 27.98 | 37.12 | 4.95 | 5.96 |
Common Stock | 0.03 | 0.02 | 0.01 | 0.01 | 0 | 0.01 |
Additional Paid-In Capital | 204.72 | 192.01 | 153.87 | 136.17 | 2.97 | 2.18 |
Retained Earnings | -193.29 | -165.26 | -135.77 | -100.06 | -71.76 | -52.55 |
Total Common Equity | 11.46 | 26.77 | 18.11 | 36.12 | -68.79 | -50.36 |
Shareholders' Equity | 11.46 | 26.77 | 18.11 | 36.12 | 17.91 | 1.61 |
Total Liabilities & Equity | 33.84 | 51.6 | 46.09 | 73.24 | 22.86 | 7.57 |
Total Debt | 17.74 | 20.66 | 22.11 | 18.54 | 2.44 | 2.36 |
Net Cash (Debt) | 4.38 | 18.57 | 9.12 | 33.29 | 16.38 | 0.88 |
Net Cash Growth | - | 103.70% | -72.62% | 103.24% | 1761.48% | - |
Net Cash Per Share | 0.19 | 1.20 | 0.79 | 8.78 | 34.99 | 1.05 |
Filing Date Shares Outstanding | 43.64 | 22.19 | 10.56 | 7.17 | 1.03 | 0.84 |
Total Common Shares Outstanding | 26.57 | 22.05 | 10.52 | 6.91 | 1.03 | 0.84 |
Working Capital | 9.58 | 30.95 | 25.67 | 48.94 | 16.6 | 0.14 |
Book Value Per Share | 0.43 | 1.21 | 1.72 | 5.23 | -66.68 | -60.06 |
Tangible Book Value | 11.46 | 26.77 | 18.11 | 36.12 | -68.79 | -50.36 |
Tangible Book Value Per Share | 0.43 | 1.21 | 1.72 | 5.23 | -66.68 | -60.06 |
Machinery | - | 1.63 | 1.54 | 1.1 | 0.82 | 0.77 |
Construction In Progress | - | - | - | - | - | 0.01 |
Leasehold Improvements | - | 0.24 | 0.88 | 0.84 | 0.75 | 0.75 |
Source: S&P Capital IQ. Standard template. Financial Sources.